Navigation Links
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
Date:3/11/2008

- - - 37,901

Total revenues 2,046,708 1,954,977 9,663,513 13,709,186

Operating expenses:

Research and

development 8,268,413 8,468,763 36,060,470 35,615,536

General and

administrative 2,820,543 3,372,108 13,569,578 12,254,892

Restructuring

charges 345,426 - 1,563,274 -

Total operating

expenses 11,434,382 11,840,871 51,193,322 47,870,428

Loss from operations (9,387,674) (9,885,894) (41,529,809) (34,161,242)

Interest income 661,381 898,786 2,971,666 3,394,751

Interest expense (57,631) (44,018) (209,885) (477,643)

Other income, net 5,949 1,124 7,108 6,873

Net loss $(8,777,975) $(9,030,002) $(38,760,920) $(31,237,261)

Basic and diluted

loss per share $(0.26) $(0.31) $(1.20) $(1.13)

Shares used in

computing basic and

diluted loss

per share 34,336,645 29,386,886 32,340,203 27,758,348


'/>"/>
SOURCE Sunesis Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Sunesis Pharmaceuticals to Present Interim Phase 2 Data for SNS-595 at the 39th Annual Meeting on Womens Cancer
2. Sunesis Pharmaceuticals Announces Milestone Payment from Inflammation Collaboration
3. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
4. Sunesis Pharmaceuticals to Report Third Quarter 2007 Financial Results
5. Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
7. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
8. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
9. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
10. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results and Clinical Program Overview on March 12, 2008
11. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by ... Systems, Table-top Counters) by End-user (Inpatient Pharmacy Automation, ... to 2019” analyzes and studies the major market ... Asia-Pacific, and the Rest of the World (RoW). ... spread through 300 pages and in-depth TOC on ...
(Date:10/20/2014)... , A major pan-European survey ... delivery of care has revealed changing trends in many ... the provision of healthcare services across the continent. The ... European Gastroenterology (UEG), have been announced today and led ... the burden of GI disorders across Europe ...
(Date:10/20/2014)... 2014 Local veterinary surgeon, Dr. Tim ... study of donor stem cells for dogs with osteoarthritis. ... and has performed clinical stem cell therapy for 7 ... determine if a single injection of donor stem cells ... reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... 2014 The Asian Automatic patient billing ... analysis and forecast of revenue. The Automatic patient billing ... $463.9 million by 2018, at a developing CAGR of ... TOC of the Asian Automatic patient billing market, to ... also provides a glimpse of the segmentation of this ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 2The Asian Automatic patient billing market is estimated to grow to around $463.9 million by 2018 - New Report by MicroMarket Monitor 3
... Mass., Feb. 10, 2011 Qteros, Inc., ... Bioprocessing (CBP) platform for the lowest-cost production ... engagements across the United States and Europe for members ... Qteros, Senior Vice President, Commercial Development and Engineering, will ...
... Feb. 10, 2011 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: ... the development and commercialization of products for central nervous ... the fourth quarter and full year ended December 31, ... year in the history of our company.  Our first ...
... tiny wires called Nanonets with iron oxide known more ... for the process of water splitting, an emerging clean fuel ... in the online edition of the Journal of the ... Wang and his clean energy lab pioneered the development of ...
Cached Biology Technology:Qteros Management to Present at Notable Alternative Energy Conferences in February 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Results 10Nanonets give rust a boost as agent in water splitting's hydrogen harvest 2
(Date:10/19/2014)... over the last 30 years contributed only marginally ... that time, according to a new study published ... "Energy access is fundamental to development: it brings ... communication, and health," says IIASA researcher Shonali Pachauri, ... access is widely agreed to be an important ...
(Date:10/17/2014)... in German . ... day in order to reproduce? And why are there two ... the latest issue of the research journal Molecular Human ... Steven Ramm from Bielefeld University Bielefeld has compiled this special ... for a female to copulate with several males in quick ...
(Date:10/16/2014)... new synthesis of recent research findings to inform their ... two states. , The Ecology and Management of ... Synthesis of the Relevant Biophysical Science and Implications for ... the U.S. Forest Service,s Pacific Northwest Research Station, is ... a synthesis of the large body of scientific information ...
Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2
... MILWAUKEE What determines plant diversity in a forest? ... But most research into forest diversity demonstrates only patterns ... for them until now. A team of ... (UWM) has shown that soil-borne pathogens are one important ...
... there was German measles. Ten years before the ... be a focus of Senate confirmation questions for Supreme Court ... the biggest part in starting to shift public attitudes about ... Reagan says in a new book. Where abortion had ...
... fish for a living pursue top profits, not necessarily top ... economic data for the past 55 years. This differs from ... down" the food web. It was assumed that catches of ... as halibut and tuna, were declining after fishers started landing ...
Cached Biology News:Soil-borne pathogens drive tree diversity in forests, study shows 2Epidemic played large role in shift of attitudes on abortion, author says 2Epidemic played large role in shift of attitudes on abortion, author says 3Industry fishing for profits, not predators 2Industry fishing for profits, not predators 3
...
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
ABI Plant AFLP Kits • EcoRI-ACA AFLP Amplification Primers...
Lipid-rich bovine serum albumin for cell culture. It is chromatographically purified and has an IgG content 1.0% (w/w)....
Biology Products: